-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JgbuHgXtV+TGth9HCGODqh8rXJWyFeZfR/BugVl4vnxh5b0NDYbm1nuQ4kmPolzx
 nVtHNGyCAZvOSYEe6LThjQ==

<SEC-DOCUMENT>0001181431-10-033436.txt : 20100616
<SEC-HEADER>0001181431-10-033436.hdr.sgml : 20100616
<ACCEPTANCE-DATETIME>20100616153809
ACCESSION NUMBER:		0001181431-10-033436
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20100614
FILED AS OF DATE:		20100616
DATE AS OF CHANGE:		20100616

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Furiex Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001484478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				271197863
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3900 PARAMOUNT PARKWAY
		STREET 2:		SUITE 150
		CITY:			MORRISVILLE
		STATE:			NC
		ZIP:			27560
		BUSINESS PHONE:		919-380-2000

	MAIL ADDRESS:	
		STREET 1:		3900 PARAMOUNT PARKWAY
		STREET 2:		SUITE 150
		CITY:			MORRISVILLE
		STATE:			NC
		ZIP:			27560

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PPD Therapeutics, Inc.
		DATE OF NAME CHANGE:	20100218

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			PHARMACEUTICAL PRODUCT DEVELOPMENT INC
		CENTRAL INDEX KEY:			0001003124
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34641
		FILM NUMBER:		10900583

	BUSINESS ADDRESS:	
		STREET 1:		929 NORTH FRONT STREET
		CITY:			WILMINGTON
		STATE:			NC
		ZIP:			28401
		BUSINESS PHONE:		9102510081

	MAIL ADDRESS:	
		STREET 1:		929 NORTH FRONT STREET
		CITY:			WILMINGTON
		STATE:			NC
		ZIP:			28401
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd279281.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2010-06-14</periodOfReport>

    <notSubjectToSection16>1</notSubjectToSection16>

    <issuer>
        <issuerCik>0001484478</issuerCik>
        <issuerName>Furiex Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>FURX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001003124</rptOwnerCik>
            <rptOwnerName>PHARMACEUTICAL PRODUCT DEVELOPMENT INC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>929 NORTH FRONT STREET</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>WILMINGTON</rptOwnerCity>
            <rptOwnerState>NC</rptOwnerState>
            <rptOwnerZipCode>28401</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2010-06-14</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>9881340</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The reporting person distributed the shares on a pro rata basis to shareholders of record as of June 1, 2010.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. By:  /s/ David L. Grange, Chief Executive Officer</signatureName>
        <signatureDate>2010-06-16</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----